Projected 10-year accumulated health and economic effect of the four main public policy measures for tobacco control
| Taxes | Argentina | Brazil | Chile | Colombia | Costa Rica | Ecuador | Mexico | Peru | Total |
| Proposed price increase through taxes | 60% | 60% | 40% | 60% | 40% | 20% | 40% | 40% | |
| Deaths averted | 17 905 (14 324–21 486) | 162 052 (131 667–192 437) | 12 321 (10 131–14 512) | 18 509 (15 187–22 068) | 954 (777–1132) | 3121 (2547–3695) | 39 556 (32 524–47 467) | 16 366 (13 248–19 483) | 270 784 (220 405–322 280) |
| CV, cancer and other disease events averted | 75 691 (60 553–90 829) | 1 040 848 (845 689–1 236 007) | 77 696 (63 884–91 509) | 93 156 (76 435–111 070) | 7612 (6196–9029) | 22 476 (18 343–26 610) | 235 918 (193 977–283 101) | 62 559 (50 643–74 475) | 1 615 957 (1 315 720–1 922 631) |
| YLL averted | 638 348 (510 678–766 017) | 6 656 314 (5 408 255–7 904 373) | 449 686 (369 742–529 630) | 677 629 (556 004–807 943) | 37 756 (30 732–44 780) | 130 323 (106 356–154 291) | 1 499 581 (1 232 989–1 799 498) | 528 770 (428 052–629 488) | 10 618 408 (8 642 807–12 636 020) |
| Healthcare cost-savings* | 1123 (899–1348) | 8753 (7112–10 395) | 1392 (1144–1639) | 753 (618–898) | 138 (113–164) | 334 (272–395) | 3260 (2680–3911) | 913 (739–1086) | 16 666 (13 577–19 837) |
| Productivity cost averted* | 816 (653–979) | 11 663 (9479–13 846) | 1026 (844–1208) | 607 (498–723) | 91 (74–107) | 251 (205–297) | 2162 (1778–2595) | 577 (467–687) | 17 193 (13 998–20 442) |
| Caregiver cost averted* | 431 (345–517) | 6427 (5222–7632) | 843 (693–993) | 371 (305–443) | 45 (37–53) | 163 (133–193) | 613 (504–735) | 521 (422–620) | 9414 (7659–11 186) |
| Increased tax revenue* | 4627 (3838–5348) | 5156 (4911–5069) | 2573 (2266–2814) | 987 (908–1024) | 199 (171–224) | 60 (56–61) | 6289 (5490–7023) | 600 (511–678) | 20 491 (18 150–22 240) |
| Total economic benefit* | 6997 (5734–8192) | 32 000 (26 724–36 942) | 5833 (4947–6654) | 2719 (2329–3088) | 474 (394–549) | 807 (666–945) | 12 323 (10 452–14 264) | 2611 (2138–3071) | 63 764 (53 385–73 705) |
| Plain packaging | |||||||||
| Deaths averted | 9519 (4998–24 127) | 35 916 (18 856–90 987) | 4369 (2294–11 069) | 6505 (5445–12 260) | 354 (186–897) | 1145 (601–2901) | 14 027 (7364–35 535) | 6218 (3264–15 752) | 78 053 (43 009–193 527) |
| CV, cancer and other disease events averted | 40 242 (21 130–101 994) | 230 684 (121 109–584 401) | 27 552 (14 465–69 798) | 32 740 (27 405–61 705) | 2825 (1483–7157) | 8245 (4329–20 888) | 83 659 (43 921–211 936) | 23 769 (12 479–60 214) | 449 716 (246 321–1 118 091) |
| YLL averted | 339 388 (178 205–860 174) | 1 475 247 (774 505–3 737 292) | 159 463 (83 718–403 973) | 238 155 (199 349–448 850) | 14 011 (7356–35 495) | 47 808 (25 099–121 112) | 531 766 (279 177–1 347 142) | 200 900 (105 473–508 948) | 3 006 739 (1 652 882–7 462 987) |
| Healthcare cost-savings* | 597 (314–1514) | 1940 (1019–4915) | 493 (259–1250) | 265 (222–499) | 51 (27–130) | 122 (64–310) | 1156 (607–2928) | 347 (182–878) | 4972 (2693–12 424) |
| Productivity cost averted* | 434 (228–1099) | 2588 (1359–6553) | 364 (191–922) | 213 (179–402) | 34 (18–85) | 92 (48–233) | 767 (403–1943) | 219 (115–555) | 4712 (2541–11 793) |
| Caregiver cost averted* | 229 (120–581) | 1424 (748–3609) | 299 (157–757) | 131 (109–246) | 17 (09–42) | 60 (31–151) | 217 (114–550) | 198 (104–501) | 2575 (1392–6438) |
| Total economic benefit* | 1260 (662–3194) | 5953 (3125–15 077) | 1156 (607–2929) | 609 (509–1147) | 102 (53–258) | 274 (144–694) | 2140 (1124–5421) | 764 (401–1935) | 12 258 (6626–30 655) |
| Advertising bans | |||||||||
| Deaths averted | 12 195 (7460–19 144) | 21 413 (11 602–61 574) | 5595 (3423–8783) | 1360 (730–4058) | 469 (277–927) | 1516 (897–2996) | 19 778 (10 988–51 643) | 8767 (4871–22 892) | 71 093 (40 248–172 016) |
| CV, cancer and other disease events averted | 51 555 (31 538–80 929) | 137 533 (74 517–395 485) | 35 281 (21 582–55 382) | 6844 (3676–20 424) | 3740 (2213–7392) | 10 916 (6459–21 576) | 117 959 (65 533–308 004) | 33 514 (18 619–87 509) | 397 342 (224 136–976 701) |
| YLL averted | 434 798 (265 978–682 524) | 879 534 (476 540–2 529 158) | 204 197 (124 913–320 537) | 49 787 (26 737–148 570) | 18 550 (10 976–36 665) | 63 294 (37 449–125 103) | 749 791 (416 550–1 957 787) | 283 270 (157 372–739 648) | 2 683 220 (1 516 516–6 539 992) |
| Healthcare cost-savings* | 765 (468–1201) | 1157 (627–3326) | 632 (387–992) | 55 (30–165) | 68 (40–134) | 162 (96–320) | 1630 (905-4256) | 489 (272–1276) | 4958 (2824–11 671) |
| Productivity cost averted* | 556 (340–872) | 1543 (836–4436) | 466 (285–732) | 45 (24–133) | 45 (26–88) | 122 (72–241) | 1082 (601–2822) | 309 (172–807) | 4167 (2357–10 131) |
| Caregiver cost averted* | 293 (180–461) | 849 (460–2442) | 383 (234–601) | 27 (15–81) | 22 (13–44) | 79 (47–156) | 306 (170–800) | 279 (155–729) | 2239 (1274–5313) |
| Total economic benefit* | 1615 (988–2534) | 3549 (1923–10 204) | 1481 (906–2324) | 127 (68–380) | 135 (80–266) | 363 (215–717) | 3018 (1677–7878) | 1077 (598–2812) | 11 364 (6455–27 116) |
| Smoke-free air | |||||||||
| Deaths averted | 2173 (853–5361) | 00 (00–00) | 00 (00–00) | 1948 (790–4300) | 81 (32–199) | 498 (202–1100) | 29 269 (14 714–43 644) | 4982 (2134–9508) | 38 951 (18 725–64 112) |
| CV, cancer and other disease events averted | 9186 (3605–22 661) | 00 (00–00) | 00 (00–00) | 9805 (3975–21 642) | 645 (253–1590) | 3589 (1455–7923) | 174 565 (87 758–260 298) | 19 043 (8157–36 344) | 216 833 (105 204–350 458) |
| YLL averted | 77 472 (30 405–191 116) | 00 (00–00) | 00 (00–00) | 71 320 (28 915–157 429) | 3197 (1255–7886) | 20 811 (8437–45 938) | 1 109 603 (557 820–1 654 551) | 160 959 (68 950–307 191) | 1 443 361 (695 782–2 364 112) |
| Healthcare cost-savings* | 136 (54–336) | 00 (00–00) | 00 (00–00) | 79 (32–175) | 12 (05–29) | 53 (22–118) | 2412 (1212–3596) | 278 (119–530) | 2970 (1443–4784) |
| Productivity cost averted* | 99 (39–244) | 00 (00–00) | 00 (00–00) | 64 (26–141) | 08 (03–19) | 40 (16–88) | 1600 (805–2386) | 176 (75–335) | 1987 (964–3214) |
| Caregiver cost averted* | 52 (21–129) | 00 (00–00) | 00 (00–00) | 39 (16–86) | 04 (01–09) | 26 (11–57) | 453 (228–676) | 159 (68–303) | 733 (344–1261) |
| Total economic benefit | 288 (113–710) | 00 (00–00) | 00 (00–00) | 182 (74–402) | 23 (09–57) | 119 (48–263) | 4466 (2245–6658) | 612 (262–1168) | 5690 (2752–9259) |
*In US$ millions.
CV, cardiovascular; YLL, years of life lost.